Literature DB >> 9246608

Roles of phospholipases A2 in brain cell and tissue injury associated with ischemia and excitotoxicity.

J V Bonventre1.   

Abstract

Phospholipase A2 (PLA2) activity is an important contributor to destructive cellular processes in the central nervous system. Two cytosolic forms of calcium dependent PLA2 have been characterized in the gerbil brain and the neuronal cultures from rat brain. PLA2 enzymatic activity in cell free extracts from cortical neuronal cultures is upregulated after cells are exposed to glutamate. Brief exposure to a calcium ionophore or phorbol 12-myristate 13-acetate (PMA) stably enhanced PLA2 activity. Stable activation of the two cytosolic forms of PLA2 occur prior to evidence of cell death and this activation is reversible. The larger molecular mass form was characterized as cPLA2. The smaller form (approximately 14 kDa) was distinct from Group I and II PLA2. Exposure to glutamate shifted the calcium activation curve of the smaller form to the left suggesting a novel mechanism of regulation of PLA2. Glutamate-induced stable enhancement of PLA2 activity, by processes involving calcium and protein kinase C activation, is a potential molecular switch likely mediating changes in synaptic function and contributing to excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246608     DOI: 10.1016/s0929-7855(97)00014-x

Source DB:  PubMed          Journal:  J Lipid Mediat Cell Signal        ISSN: 0929-7855


  9 in total

1.  Inhibition of cPLA2 activation by Ginkgo biloba extract protects spinal cord neurons from glutamate excitotoxicity and oxidative stress-induced cell death.

Authors:  Zhen Zhao; Naikui Liu; Jingya Huang; Pei-Hua Lu; Xiao-Ming Xu
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

Review 2.  Neuroprotection for ischemic stroke: past, present and future.

Authors:  Myron D Ginsberg
Journal:  Neuropharmacology       Date:  2008-03-04       Impact factor: 5.250

Review 3.  Phospholipases A2 in ischemic and toxic brain injury.

Authors:  A Sapirstein; J V Bonventre
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

4.  cPLA2α-/- sympathetic neurons exhibit increased membrane excitability and loss of N-Type Ca2+ current inhibition by M1 muscarinic receptor signaling.

Authors:  Liwang Liu; Joseph V Bonventre; Ann R Rittenhouse
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

5.  Cytosolic phospholipase A(2) alpha mediates electrophysiologic responses of hippocampal pyramidal neurons to neurotoxic NMDA treatment.

Authors:  Ying Shen; Koji Kishimoto; David J Linden; Adam Sapirstein
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

Review 6.  Inflammation in central nervous system injury.

Authors:  Stuart M Allan; Nancy J Rothwell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-10-29       Impact factor: 6.237

7.  Translationally Controlled Tumor Protein Stimulates Dopamine Release from PC12 Cells via Ca2+-Independent Phospholipase A₂ Pathways.

Authors:  Jihui Seo; Jeehye Maeng; Hwa-Jung Kim
Journal:  Int J Mol Sci       Date:  2016-10-24       Impact factor: 5.923

8.  Early upregulation of cytosolic phospholipase A2α in motor neurons is induced by misfolded SOD1 in a mouse model of amyotrophic lateral sclerosis.

Authors:  Yafa Fetfet Malada Edelstein; Yulia Solomonov; Nurit Hadad; Leenor Alfahel; Adrian Israelson; Rachel Levy
Journal:  J Neuroinflammation       Date:  2021-11-25       Impact factor: 8.322

Review 9.  Excitotoxicity: Still Hammering the Ischemic Brain in 2020.

Authors:  Dennis W Choi
Journal:  Front Neurosci       Date:  2020-10-26       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.